Private LLM in Pharma: Air-Gapped AI Architecture Guide
Examine how pharma organizations deploy private LLMs using air-gapped AI architecture to maintain data sovereignty and comply with FDA and GDPR regulations.
Back to Articles
Articles tagged with “pharma-ai”
EU Digital Omnibus: Pharma & Medical Device AI Compliance
Examine how the EU Digital Omnibus impacts pharma AI and medical device compliance. Review AI Act timeline extensions, MDR integration, and GDPR data updates.
Pharma AI Pilots: Why PoCs Fail and Scaling Strategies
Learn why 95% of pharma AI pilots fail to reach production. This guide explains PoC failure causes, data integration challenges, and strategies for scaling.
Pharma AI Change Management: Upskilling and Literacy
Explore pharma AI change management and organizational readiness strategies. Understand how life science companies build AI literacy to address skills gaps.
Agentic AI in Pharma: Scaling from Pilot to Production
Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.
Pharma AI Pilots: Fixing Data Foundations for Scale
Examine why most pharma AI pilots fail to reach production. This report analyzes data fragmentation, governance issues, and building scalable data foundations.
Pharma AI Vendor Due Diligence: A Validation Checklist
Learn to validate AI vendor claims in pharma. This due diligence checklist covers GxP compliance, data security, and model performance verification methods.
ISPE GAMP AI Guide: Validation Framework for GxP Systems
Review the ISPE GAMP AI Guide for validating machine learning in GxP. Learn the risk-based framework for data integrity and regulatory compliance.
Private LLM Deployment in Pharma: Architecture & Compliance
Learn to deploy private LLMs in pharma. This guide covers compliant architecture, including on-premise & cloud, and navigating HIPAA, GxP, and FDA regulations.
AI for Biotech: A Build vs. Buy Decision Framework
A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, and vendor evaluation criteria.
Claude Opus 4.5: An Analysis of AI for Healthcare & Pharma
A technical overview of Claude Opus 4.5 and 4.6, state-of-the-art AI models for coding. Learn their capabilities for software development in healthcare and pharma. Updated February 2026.
Veeva AI Agents: Agentic AI for the Life Sciences Industry
An in-depth analysis of Veeva AI Agents, the agentic AI integrated into the Veeva Vault platform for life sciences. Covers the December 2025 launch, early adopter results from Moderna and BMS, customer wins from Roche and Novo Nordisk, and the 2026 rollout roadmap.